[1] |
ZHANG Ren⁃jie, PANG Hua⁃sheng, LI Jing⁃zhong, LUO Zhao⁃hui, AI Lin, SONG Peng, CAI Yu⁃chun, LU Yan, MO Xiao⁃jin, CHEN Mu⁃xin , CHEN Jia⁃xu.
Mechanism of hepatic fibrosis associated with Echinococcus: a review
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(6): 646-.
|
[2] |
LI Zi⁃ang, JIAO Yi⁃ping, XU Jun.
Current status and prospects of artificial intelligence in schistosomiasis prevention and control
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(5): 453-.
|
[3] |
ZHAN Ting-zheng, MA Hui-hui, LI Qing, TANG Li-li, HE Shan⁃shan, TANG Ze-li, XIA Chao⁃ming.
Interleukin-9 promotes the activation of hepatic stellate cells in mice infected with Schistosoma japonicum
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(5): 514-.
|
[4] |
DU Zhi⁃xiang, LI Yang, WANG Zi⁃jian, ZHOU Da⁃ming, YANG Jiang⁃hua.
Bioinformatics analysis of differentially expressed genes associated with chronic schistosomiasis japonica⁃induced hepatic fibrosis
[J]. Chinese Journal of Schistosomiasis Control, 2022, 34(4): 352-.
|
[5] |
YUAN Xuan, DAI Jian⁃Rong.
Progress of researches on the actions of praziquantel against hepatic fibrosis
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(5): 540-.
|
[6] |
CAO Tao, YANG Yu⁃Wen, YANG Xiao, ZHU Hai⁃Hong.
Expression and significance of TGF⁃β1, p38MAPK and BMP⁃7 protein in liver specimens of patients with alveolar hepatic echinococcosis
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(4): 353-.
|
[7] |
ZHOU Li-Yun, WU Yi-Ming, ZHANG Li-Fang.
Serum vitamin D expression in advanced schistosomiasis patients with hepatic fibrosis and its association with disease progression
[J]. Chin J Schisto Control, 2020, 32(3): 304-.
|
[8] |
ZHANG Jia-Ning, QU Hai-Yan, ZHANG Jin-Meng, FENG Jin-Mei, SONG Wen-Jian, YUAN Fa-Hu.
Polysaccharide from Phellinus igniarius alleviates oxidative stress and hepatic fibrosis in Schistosoma japonicum?infected mice
[J]. Chin J Schisto Control, 2019, 31(6): 615-.
|
[9] |
ZHOU Yong-Hua, XU Chen, YANG Ying-Ying, MEI Cong-Jin, DONG Pan-Pan, SAI Xue, XU Yong-Liang, FAN Xiao-Lin,YANG Jun-Qi, SHEN Li-Juan.
Roles of transforming growth factor-β1 and heat shock protein 47 in progression of Schistosoma japonicum-induced hepatic fibrosis
[J]. Chin J Schisto Control, 2019, 31(4): 382-.
|
[10] |
ZHOU Yong-Hua, TANG Xian-Shi, SHEN Li-Juan, DONG Xuan, WANG Ke, YANG Jun-Qi, XU Yong-Liang.
Advances in the regulatory roles of exosomes on pathological process of schistosomiasis hepatic fibrosis
[J]. Chin J Schisto Control, 2018, 30(5): 596-600.
|
[11] |
NIU Xue-Hua, HUA Hai-Yong, GUO Wen-Jian, HONG Ye, YOU Lu, DENG Yong, CHEN Wei.
Effectiveness of clinical pathway for treatment of advanced schistosomiasis hepatic fibrosis
[J]. Chin J Schisto Control, 2017, 29(4): 475-477.
|
[12] |
WANG Xian-Mo, ZHANG Jia-Jun, XIAO Lin.
Correlation between hepatic fibrosis and anti-neutrophil cytoplasmic antibodies (ANCA) in schistosomiasis patients
[J]. Chin J Schisto Control, 2017, 29(3): 380-382.
|
[13] |
ZHU Yi, JI Min.
Clinical characteristics of 96 patients with advanced schistosomiasis in
Yingcheng City
[J]. Chin J Schisto Control, 2016, 28(4): 470-471.
|
[14] |
CAI Wen, ZHAO Lei, LI Hua-Rong, ZHANG Shu-Ling.
Influence of kaempferol on TGF?β1/Smads signal path in liver tissue of mice with with Schistosoma japonicum infection
[J]. Chin J Schisto Control, 2014, 26(4): 399-.
|
[15] |
LUO Fu-Jun, YAO Zuo-Ping, YANG Su.
Long -term therapeutic effect of Ruangan Pills on advanced schistosomiasis patients with ascites
[J]. Chin J Schisto Control, 2014, 26(1): 103-.
|